Inhibikase Therapeutics, Inc. - Common Stock (IKT)

1.5750
-0.0350 (-2.17%)
NASDAQ· Last Trade: May 19th, 3:10 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors